Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Uniqure N.V. (QURE)

$50.88 0.00 (0.00%)

19:13 EST QURE Stock Quote Delayed 15 Minutes

Volume:

Previous Close $50.88

Market Cap 1.61B

PE Ratio -

EPS -

Volume (Avg. Vol.)

Day's Range 50.88 - 50.88

52-Week Range 24.07 - 82.49

Dividend & Yield N/A (N/A)

QURE Stock Predictions, Articles, and Uniqure N.V. News

From InvestorPlace
From the Web

7 Stocks to Buy With Over 20% Upside From Current Levels

By Harriet Lefton, Writer, TipRanks Jul 30, 2019

As stocks keep pushing to highs again and again, where can you find smart stocks to buy right now? Check out these 7 excellent options.

3 Top Gene Therapy Stocks That Could Soar

By Aaron Levitt, InvestorPlace Contributor May 30, 2019

Biotech stocks targeting gene therapy are going to be huge. Here are 3 gene therapy stocks to buy that have a ton of potential.

Play The Future of Gene Therapy With These 5 Biotech Stocks

By Aaron Levitt, InvestorPlace Contributor Aug 27, 2018

What's the next big thing in biotech? The answer is gene therapy and these five biotech stocks are leading the way.

7 Triple-A Stocks to Buy — With 100% Street Support

By Harriet Lefton, Writer, TipRanks May 22, 2018

These 7 'Strong Buy' stocks all have 100 % buy ratings from the Street. We use our big data capabilities to track the latest ratings from over 4,700 analysts. Here we delve down into why the Street is so bullish on our 7 top stocks to buy ideas.

Best & Worst Performing Mid Cap Stocks for November 21, 2019

From StockNews.com Nov 21, 2019

ACB – ACB leads the way today as the best performing mid cap stock, closing up 18.18%.

Is uniQure (NASDAQ:QURE) Weighed On By Its Debt Load?

From Simply Wall St Nov 20, 2019

The external fund manager backed by Berkshire Hathaway’s Charlie Munger, Li Lu, makes no bones about it when he says ‘The biggest investment risk is not the volatility of prices,<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/is-uniqure-nasdaqqure-weighed-on-by-its-debt-load-2/">Read More...</a></div>

uniQure N.V. (QURE) Shares March Higher, Can It Continue?

From Zacks Investment Research Nov 7, 2019

As of late, it has definitely been a great time to be an investor in uniQure N.V. (QURE).

Benzinga's Top Upgrades, Downgrades For November 5, 2019

From Benzinga Nov 5, 2019

Upgrades Rosenblatt upgraded the stock for Applied Optoelectronics Inc (NASDAQ: AAOI) from Neutral to Buy. Applied Optoelectronics earned ($0.26) in the second quarter,...

uniQure N.V. Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

From Simply Wall St Oct 30, 2019

uniQure N.V. (NASDAQ:QURE) just released its latest third-quarter report and things are not looking great. Earnings fell catastrophically short of expectations, with revenues of US$1.0m missing forecasts by 53%. Losses<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/uniqure-n-v-just-reported-third-quarter-earnings-and-analysts-are-lifting-their-estimates/">Read More...</a></div>

uniQure N.V. (QURE) Shares March Higher, Can It Continue?

From Zacks Investment Research Oct 30, 2019

As of late, it has definitely been a great time to be an investor in uniQure N.V. (QURE).

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!